The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches

BACKGROUND: Risk stratification or progression in prostate cancer is performed with the support of clinical-pathological data such as the sum of the Gleason score and serum levels PSA. For several decades, methods aimed at the early detection of prostate cancer have included the determination of PSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Alarcón-Zendejas, Ana Paula, Scavuzzo, Anna, Jiménez-Ríos, Miguel A., Álvarez-Gómez, Rosa M., Montiel-Manríquez, Rogelio, Castro-Hernández, Clementina, Jiménez-Dávila, Miguel A., Pérez-Montiel, Delia, González-Barrios, Rodrigo, Jiménez-Trejo, Francisco, Arriaga-Canon, Cristian, Herrera, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385485/
https://www.ncbi.nlm.nih.gov/pubmed/35422101
http://dx.doi.org/10.1038/s41391-022-00537-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385485/
https://www.ncbi.nlm.nih.gov/pubmed/35422101
http://dx.doi.org/10.1038/s41391-022-00537-2

Ejemplares similares